426 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SNY Sanofi $43.75 $109.14B Downtrend
Article Searches
Congress Grills Drugmakers: 5 Key Takeaways https://www.fool.com/investing/2019/02/26/congress-grills-drugmakers-5-key-takeaways.aspx?source=iedfolrf0000001 Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
2 More Gene Therapy Stocks on Big Pharma's Buyout Radar https://www.fool.com/investing/2019/02/26/2-more-gene-therapy-stocks-on-big-pharmas-buyout-r.aspx?source=iedfolrf0000001 Feb 26, 2019 - Roche's big step into the gene-editing space will spark interest for these two stocks.
Ascendis Pharma Files IND for Hypoparathyroidism Candidate http://www.zacks.com/stock/news/354249/ascendis-pharma-files-ind-for-hypoparathyroidism-candidate?cid=CS-ZC-FT-354249 Feb 13, 2019 - Ascendis Pharma (ASND) submits regulatory application to initiate a phase II study in the United States on its hypoparathyroidism therapy candidate, TransCon PTH.
Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs http://www.zacks.com/stock/news/353203/pharma-stock-roundup-q4-earnings-at-mrk-lly-chmp-nod-for-several-drugs?cid=CS-ZC-FT-353203 Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/353200/alnylams-alny-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-353200 Feb 08, 2019 - Alnylam (ALNY) incurs wider year-over-year loss in the fourth quarter of 2018.
Sanofi (SNY) CEO Olivier Brandicourt on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4239163-sanofi-sny-ceo-olivier-brandicourt-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 07, 2019 -
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth http://www.zacks.com/stock/news/352788/sanofi-sny-q4-earnings-top-genzyme-unit-drives-sales-growth?cid=CS-ZC-FT-352788 Feb 07, 2019 - Sanofi (SNY) beat estimates for earnings and missed the same for sales in the fourth quarter. The Specialty Care unit drove top-line growth.
Regeneron Q4 Earnings & Sales Beat on Strong Dupixent, Eylea http://www.zacks.com/stock/news/352622/regeneron-q4-earnings-sales-beat-on-strong-dupixent-eylea?cid=CS-ZC-FT-352622 Feb 06, 2019 - Regeneron's (REGN) earnings and sales surpass expectations in Q4 on solid Dupixent and Eylea sales.
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA http://www.zacks.com/stock/news/352502/the-zacks-analyst-blog-highlights-pepsico-disney-sanofi-diageo-and-hca?cid=CS-ZC-FT-352502 Feb 06, 2019 - The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
Top Ranked Income Stocks to Buy for February 6th http://www.zacks.com/commentary/211460/top-ranked-income-stocks-to-buy-for-february-6th?cid=CS-ZC-FT-211460 Feb 06, 2019 - Top Ranked Income Stocks to Buy for February 6th

Pages: 12345678...43

<<<Page 3>